New And Special Drugs
Anxu (Rovadicitinib) – Myelofibrosis | HongKong DengYue Medicine
Goxblem (Bemiltenase alfa) – Hemophilia A/B | HongKong DengYue Medicine
Kardorisso (Asandeutertinib) – NSCLC | HongKong DengYue Medicine
Atled (Fanregratinib) – Intrahepatic Cholangiocarcinoma | HongKong DengYue Medicine
Redemplo (Plozasiran) – FCS | HongKong DengYue Medicine
Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine
Qiyoukang (Gumokimab) – Plaque Psoriasis | HongKong DengYue Medicine
Lukeda (Rocbrutinib) – MCL | HongKong DengYue Medicine
What Can We Offer You?
Generic drugs
Dedicated to providing high-quality, affordable medicines around the world
Vitamins and Supplements
A balanced diet by addressing different deficiencies with the right dosage
brand name medicines
DengYue Medicine as China Drug Import and Export Wholesaler, fills the gap between quality and quantity by adding some affordability
Fast-moving consumer goods
Stock a full range of products from sanitary napkins to foot care creams for your daily needs
non-prescription drugs
Flagship OTC brand - approved and accepted by global standards
Medical supplies and auxiliary supplies
Explore continually updated supplies, diagnostic equipment and essential tools
News
HongKong DengYue Medicine Wholesaler focus on medical trends and obtain new drug directions.
Top 10 Countries for China Pharmaceutical Exports—Based on DengYueMed’s Global Business Insights
China’s pharmaceutical export markets span North America, Europe, Asia, Latin America, Africa, and Oceania. Pharmaceutical exports from China are expanding from traditional APIs and generic
How to Get Chinese Medicines Delivered to Your Door: In China or Overseas
Getting access to medicines is becoming increasingly convenient. In China, the combination of online pharmacy platforms and local physical drugstores makes it easier to search
Sanofi’s Rilzabrutinib Approved in China: First BTK Inhibitor for Immune Thrombocytopenia (ITP)
On September 3, 2026, China’s NMPA website showed that Sanofi’s rilzabrutinib tablets had been approved for adults with persistent or chronic primary immune thrombocytopenia (ITP)
Rare Disease Drugs in China: 6 Innovative Medicines Approved in H1 2026 and Their Indications
In the first half of 2026, the field of rare disease drugs in China continued to see new regulatory approvals, including six innovative medicines. DengYueMed
Innovative Lung Cancer Drug Asandeutertinib Approved: Deuterated Third-Generation EGFR-TKI for Brain Metastases
Treatment options for EGFR-mutated lung cancer continue to expand, but for patients with central nervous system (CNS) metastases, intracranial disease control remains an important clinical
How China Online Pharmacies Work: Online-Offline Integration and Global User Services
Key Takeaways As international interest in Chinese medicines and pharmaceutical resources continues to grow, finding convenient ways to understand medicines and related pharmacy services in
Innovative Plaque Psoriasis Drug Lecankitug Approved: The World’s Second IL-17A/F Dual-Target Drug
The psoriasis biologics market is gradually moving from single-target competition toward more differentiated mechanism-based competition. In August 2026, information published on the official website of
What Medicines Can Be Sourced from China? A Guide for B2B Pharmaceutical Buyers
China has a large and well-established pharmaceutical research, manufacturing, and supply system, making it an important participant in the global pharmaceutical supply chain. For overseas
Fast And Safe Delivery
Global Transportation Express
Temperature-controlled Transport
Safe Transportation, GDP Compliant
